231 related articles for article (PubMed ID: 16188652)
21. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling defines a high-risk entity of multiple myeloma.
Zhan FH; Barlogie B; John D S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):191-203. PubMed ID: 17478923
[TBL] [Abstract][Full Text] [Related]
23. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
24. Using genomics to identify high-risk myeloma after autologous stem cell transplantation.
Shaughnessy JD; Barlogie B
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):77-80. PubMed ID: 16399589
[TBL] [Abstract][Full Text] [Related]
25. Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.
Filipits M; Pohl G; Stranzl T; Kaufmann H; Ackermann J; Gisslinger H; Greinix H; Chott A; Drach J
Clin Cancer Res; 2003 Feb; 9(2):820-6. PubMed ID: 12576455
[TBL] [Abstract][Full Text] [Related]
26. Role of Cks1 amplification and overexpression in breast cancer.
Wang XC; Tian J; Tian LL; Wu HL; Meng AM; Ma TH; Xiao J; Xiao XL; Li CH
Biochem Biophys Res Commun; 2009 Feb; 379(4):1107-13. PubMed ID: 19161979
[TBL] [Abstract][Full Text] [Related]
27. Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancers.
Sanada T; Yokoi S; Arii S; Yasui K; Imoto I; Inazawa J
Cancer Sci; 2004 Dec; 95(12):969-76. PubMed ID: 15596046
[TBL] [Abstract][Full Text] [Related]
28. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
[TBL] [Abstract][Full Text] [Related]
29. Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma.
Xu J; Sun Y; Jiang J; Xu Z; Li J; Xu T; Liu P
Front Immunol; 2020; 11():1292. PubMed ID: 32760394
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.
Inoue J; Otsuki T; Hirasawa A; Imoto I; Matsuo Y; Shimizu S; Taniwaki M; Inazawa J
Am J Pathol; 2004 Jul; 165(1):71-81. PubMed ID: 15215163
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
[TBL] [Abstract][Full Text] [Related]
32. Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
Grzasko N; Hus M; Pluta A; Jurczyszyn A; Walter-Croneck A; Morawska M; Chocholska S; Hajek R; Dmoszynska A
Hematol Oncol; 2013 Mar; 31(1):41-8. PubMed ID: 22674819
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of p27Kip1 arrests neuroblastoma cell growth.
Matsuo T; Seth P; Thiele CJ
Med Pediatr Oncol; 2001 Jan; 36(1):97-9. PubMed ID: 11464914
[TBL] [Abstract][Full Text] [Related]
34. 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Chang H; Qi X; Jiang A; Xu W; Young T; Reece D
Bone Marrow Transplant; 2010 Jan; 45(1):117-21. PubMed ID: 19448682
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study.
Liu Z; Fu Q; Lv J; Wang F; Ding K
J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157
[TBL] [Abstract][Full Text] [Related]
36. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of 1q21 amplification in multiple myeloma].
Abramova TV; Obukhova TN; Mendeleeva LP; Pokrovskaya OS; Gribanova EO; Ryzhko VV; Grebenyuk LA; Nareyko MV; Solovyev MV; Votyakova OM; Kulikov SM; Rusinov MA; Savchenko VG
Ter Arkh; 2017; 89(7):32-38. PubMed ID: 28766538
[TBL] [Abstract][Full Text] [Related]
38. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
[TBL] [Abstract][Full Text] [Related]
39. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of p27Kip1 deregulation in colorectal cancer.
Hershko DD; Shapira M
Cancer; 2006 Aug; 107(4):668-75. PubMed ID: 16826582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
